dr. hussain on the clinical impact of the profound trial in mcrpc
Published 4 years ago • 138 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:33
dr. hussain on the implications of the profound trial in mcrpc
-
1:32
dr. hussain on results of the profound trial in mcrpc
-
16:07
profound trial shows increased rpfs in mcrpc patients with brca1, brca2, and atm mutations
-
4:30
profound: olaparib for hrr mcrpc
-
2:40
researcher comment: profound improvement in outcomes with olaparib in mcrpc | maha hussain
-
1:50
dr. hussain on the rationale to target the dna repair pathway in mcrpc
-
2:38
maha hussain, md, shares the design of the phase iii profound study in mcrpc
-
2:21
dr. hussain on the treatment of nonmetastatic crpc
-
48:10
urowebinar: paradigm shifts in metastatic hormone sensitive prostate cancer: recnt treatmnt dvlpmnts
-
26:28
advances in non-metastatic prostate cancer: navigating arpis and precision diagnostics
-
21:13
treating aggressive prostate cancer with maha hussain, md
-
1:11
dr. maha hussain on novel approaches in prostate cancer
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
1:47
dr. hussain on potential of enzalutamide in prostate cancer
-
10:55
emerging therapies for advanced prostate cancer
-
1:01
dr. hussain on interest in using parp inhibitors in prostate cancer
-
1:51
dr. hussain discusses findings with parp inhibitors in prostate cancer
-
5:31
updates on the systemic treatment of metastatic hspc
-
3:55
optimal treatment approaches for mcrpc
-
1:32
dr. hussain discusses parp inhibitors in prostate cancer
-
5:19
profound trial and other recent updates in prostate cancer
-
1:25
parp inhibitors: their applications and efficacy against prostate cancer